Recruitment commenced for second cohort of 6 patients at higher efti dose combined with avelumab
• No new safety signals in the first cohort, with 1 patient reporting a partial response
• More data expected to be reported in H1 CY2020
Ann: INSIGHT-004 clinical trial update, page-3
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.3¢ |
Change
0.008(2.46%) |
Mkt cap ! $443.6M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.5¢ | 31.3¢ | $31.93K | 101.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 132260 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 36900 | 8 |
View Market Depth
| Last trade - 10.28am 17/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |